MICROCHIP TECHNOLOGY INCORPORATED (MCHPP) Total liabilities 2017–2026
MICROCHIP TECHNOLOGY INCORPORATED (MCHPP) total liabilities at each fiscal year-end, per SEC filings.
$7.9BFY2026 · since FY2017: $4.4B → $7.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $7.9B | -4.3% |
| FY2025 | $8.3B | -10.0% |
| FY2024 | $9.2B | -6.5% |
| FY2023 | $9.9B | -4.3% |
| FY2022 | $10.3B | -7.5% |
| FY2021 | $11.1B | -5.9% |
| FY2020 | $11.8B | -9.4% |
| FY2019 | $13.1B | +162.4% |
| FY2018 | $5.0B | +12.7% |
| FY2017 | $4.4B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MCHPP financial trends
MCHPP RevenueMCHPP Net incomeMCHPP Net marginMCHPP Gross profitMCHPP Gross marginMCHPP Operating incomeMCHPP Operating marginMCHPP Operating cash flowMCHPP Free cash flowMCHPP Capital expendituresMCHPP Return on equityMCHPP Stock buybacksMCHPP Dividends paidMCHPP Total assetsMCHPP Shareholders’ equityMCHPP overview →